Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolism

Overview of attention for article published in Thrombosis Journal, October 2014

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 18 X posts from 18 X users, with an upper bound of 29,310 followers.

RT @Angiologist: Have you ever wondered why rivaroxaban is given 15 mg BID and then 20 mg once a day for VTE? Well... Wonder no more! Just…

RT @Angiologist: Have you ever wondered why rivaroxaban is given 15 mg BID and then 20 mg once a day for VTE? Well... Wonder no more! Just…

RT @Angiologist: Have you ever wondered why rivaroxaban is given 15 mg BID and then 20 mg once a day for VTE? Well... Wonder no more! Just…

RT @Angiologist: Have you ever wondered why rivaroxaban is given 15 mg BID and then 20 mg once a day for VTE? Well... Wonder no more! Just…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 14 additional X posts.